Sector consensus Quoin Pharmaceuticals, Ltd.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 06/03/2026 GMT			5-day change	1st Jan Change
8.670 ^USD	+1.17%		+3.58%	-39.92%

01-27	Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome	CI
01-20	Quoin, Inc. Announces Application for Breakthrough Medicine Designation with the SFDA for QRX003	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
QUOIN PHARMACEUTICALS, LTD.	US$26.33	+203.73%	3
LONZA GROUP AG	CHF 679.23	+34.71%	22
BEONE MEDICINES AG	US$409.68	+36.05%	25
CELLTRION, INC.	₩253,695.65	+19.39%	23
IQVIA HOLDINGS INC.	US$235.52	+34.98%	21
REVOLUTION MEDICINES, INC.	US$129.35	+31.45%	20
ASCENDIS PHARMA A/S	US$247.03	+18.7%	16
MEDPACE HOLDINGS, INC.	US$489.62	+4.04%	13
EUROFINS SCIENTIFIC SE	€71.71	+11.04%	14
IONIS PHARMACEUTICALS, INC.	US$93.9	+26.82%	22
TEMPUS AI, INC.	US$77.5	+48.3%	14
QIAGEN N.V.	US$55.23	+23.98%	15
PRAXIS PRECISION MEDICINES, INC.	US$600.71	+93.33%	17
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$197.2	+13.03%	15
ABIVAX	€108.72	+15.66%	6
BIO-TECHNE CORPORATION	US$75.25	+39.64%	12
ICON PUBLIC LIMITED COMPANY	US$142.86	+33.26%	14
KYMERA THERAPEUTICS, INC.	US$119.71	+43.39%	21
HANGZHOU TIGERMED CONSULTING CO., LTD	CN¥67.77	+18.13%	14
Average	13,553.84	+39.45%	16
Weighted average by Cap.	27,951.72	+29.91%	19